Fig. 4 | Signal Transduction and Targeted Therapy

Fig. 4

From: The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives

Fig. 4

Current clinical strategies in pancreatic cancer. For patients with pancreatic cancer, the primary clinical strategies rely on chemotherapy, whereas novel therapeutic agents targeting DNA repair, gene mutations, tumor metabolism, tumor microenvironments, or immune checkpoints might improve their prognosis. Currently, increasing interest has emerged in combined chemotherapy and immunotherapy or targeted therapy

Back to article page